Sharon Shacham, President & CSO at Karyopharm Therapeutics Inc. (KPTI), sold 18,990 shares at $14.83 ($282K) on 2021-02-18, disclosed to the SEC on 2021-02-22.
Open-market sale of $282k KPTI by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.83 | 9,495 | $141K | 50.0% |
| 2 | $14.83 | 9,495 | $141K | 50.0% |
| Total | $14.83 avg | 18,990 | $282K | 100% |
| Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |
| KPTI | SELL | 2021-03-23 | $50K | — | Filing → |
| KPTI | SELL | 2021-02-17 | $411K | — | Filing → |